Mycophenolate mofetil treatment for steroid resistant nephrotic syndrome

Mycophenolate mofetil treatment for steroid resistant nephrotic syndrome - Mycophenolate mofetil treatment for steroid resistant nephrotic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002740

Enrollment

Registered

2009-11-15

Start date

2009-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

steroid resistant nephrotic syndrome

Interventions

Mycophenolate mofetil (Cellcept 250mg capsule) 3 to 4 capsule a day.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: steroid resistant nephrotic syndrome ( no responder who treated with prednisolone 2 mg/kg/day or 60 mg/m2/day for 4 weeks)

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
remission	—

Countries

Japan

Contacts

Public ContactHitoshi Nakazato

Kumamoto University, Faculty of Medical and Pharmaceutical Sciences Department of Pediatrics

hnakazat@fc.kuh.kumamoto-u.ac.jp096-373-5191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026